Neuro eyes Eastern Europe

NASDAQ OMX Europe (Neuro) has announced that it plans to offer trading in blue chip securities listed on the Budapest Stock Exchange, Warsaw Stock Exchange and Prague Stock Exchange, with clearing house EMCF providing central counterparty (CCP) clearing services for the new markets. This expansion into Eastern Europe is expected to take place in Q1 2010 and is subject to regulatory approval.